This is in line with the report by Morisaki and coworkers, who reported that Gemcitabine enhances the expression of MICA/B in the hepatocellular carcinoma line HepG2, but the molecular mechanisms of the Gemcitabine-induced MICA/B expression was not analyzed [41]. The gene discussed is MICA; the disease is hepatocellular carcinoma.